The EHA 2024 (European Hematogoly Association) Hybrid Congress took place from June 13th to June 16th, 2024, in Madrid, Spain.
This year’s event was primarily an in-person event with virtual broadcasts available.
The program at a glance is available here. With this social media analysis, we will be assessing the impact of the congress online.
Scope
The scope of the analysis is focused on mentions coming worldwide.*
There were a total of 8K mentions recorded during the listening period from June 06th, 2023, to June 23rd, 2023 (one week before and two weeks after the conference).
All mentions came from X (formerly known as Twitter.).
A total of 2K unique authors were identified.
*#eha24 OR #eha2024 OR (eha NEAR/2 (2024 OR 24))
Methodology
Volume of conversations
Overall volume of mentions was significantly up when compared to last year with an increase of 54% when compared to 2023. HCPs represent the largest type of uses when compared to organizations and pharma and med companies.
Volume of mentions overtime EHA 2023: HCPs
Top hashtags
The top hashtag was
#lymsm
(lymphoma social media).
Also of note, the use of the hashtags #youngeha reserved for junior members of EHA
The official hashtag #eha2024 was the most used one with the variation #eha24 in second place.
SOV of clinical trials most discussed
Focus on Multiple Myeloma : CASSIOPEIA trial continues to impress
Long-term follow-up of the CASSIOPEIA clinical trial was presented during EHA 2024 and was the most mentioned clinical trial when it comes to multiple myeloma.
Results showed that more than 80% of the patients were still alive after 8 years in the daratumumab-VTD arm of the trial.
Topics of discussions (type of treatment)
Volume of mentions
Most mentioned clinical trials
👇 Interested in the full report? You can access it here 👇
Find out more about Social Media Intelligence just here!